Phoenix Financial’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$57.6M Sell
5,111,006
-1,070,263
-17% -$14.2M 0.39% 61
2026
Q2
$90.2M Buy
6,181,269
+2,000,000
+48% +$26.4M 0.62% 44
2026
Q1
$57.6M Buy
4,181,269
+1,670,495
+67% +$25.2M 0.55% 45
2025
Q4
$45.3M Buy
2,510,774
+3,678
+0.1% +$66K 0.49% 41
2025
Q3
$46.5M Buy
2,507,096
+492,479
+24% +$7.74M 0.57% 40
2025
Q2
$32.2M Buy
2,014,617
+1,219,958
+154% +$21.7M 0.43% 46
2025
Q1
$15.4M Sell
794,659
-618,765
-44% -$13M 0.24% 71
2024
Q4
$31.1M Sell
1,413,424
-853,573
-38% -$16.4M 0.42% 49
2024
Q3
$38.2M Sell
2,266,997
-575,336
-20% -$8.54M 0.56% 38
2024
Q2
$34M Sell
2,842,333
-546,197
-16% -$6.1M 0.52% 41
2024
Q1
$37.6M Sell
3,388,530
-666,800
-16% -$6.81M 0.52% 44
2023
Q4
$39.6M Sell
4,055,330
-1,968,766
-33% -$15.3M 0.65% 39
2023
Q3
$46.1M Sell
6,024,096
-328,344
-5% -$2.46M 0.84% 30
2023
Q2
$45.7M Buy
6,352,440
+4,903
+0.1% +$28.6K 0.93% 30
2023
Q1
$38.6M Buy
6,347,537
+392,849
+7% +$2.13M 0.86% 40
2022
Q4
$24.6M Buy
5,954,688
+1,811
+0% +$8.09K 0.48% 47
2022
Q3
$23.8M Buy
5,952,877
+1,394,935
+31% +$6.99M 0.53% 54
2022
Q2
$23.2M Buy
4,557,942
+2,261,597
+98% +$11.8M 0.47% 61
2022
Q1
$14.7M Buy
2,296,345
+1,727,379
+304% +$11.5M 0.25% 87
2021
Q4
$4.56M Buy
+568,966
New +$5.36M 0.08% 131

Other funds holding CLBT

Phoenix Financial's CLBT Position: Q3 2026 in Review

Phoenix Financial reduced its Cellebrite (CLBT) stake by 17% in Q3 2026, selling an estimated $14.2M and leaving 5,111,006 shares worth $57.6M. The position accounts for 0.39% of the portfolio, ranked #61.

Phoenix Financial first reported a position in CLBT in Q4 2021 and has held it in 20 quarters since. The position peaked at $90.2M in Q2 2026. 67 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

  • Phoenix Financial held 5,111,006 shares of Cellebrite worth $57.6M as of Q3 2026.
  • Phoenix Financial sold 1,070,263 Cellebrite shares in Q3 2026, an estimated $14.2M.
  • Cellebrite made up 0.39% of Phoenix Financial's portfolio in Q3 2026, its #61 holding.
  • Phoenix Financial first reported a position in Cellebrite in Q4 2021 and has held it in 20 quarters since.
  • Phoenix Financial's Cellebrite position peaked at $90.2M in Q2 2026.
  • 67 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on Phoenix Financial's 13F filing for Q3 2026, filed 9 Nov 2026.